Detalles de la búsqueda
1.
Estimation of liver fibrosis by noncommercial serum markers in comparison with transient elastography in patients with chronic hepatitis C virus infection receiving direct-acting antiviral treatment.
J Viral Hepat
; 26(2): 224-230, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30315694
2.
Long-term outcome of chronic hepatitis C virus infection in a real-world setting: The German LOTOS study.
Liver Int
; 37(10): 1468-1475, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28247572
3.
Treatment of HCV genotype 2 with sofosbuvir and ribavirin results in lower sustained virological response rates in real life than expected from clinical trials.
Liver Int
; 37(2): 205-211, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27428297
4.
Treatment of hepatitis C genotype 1 infection in Germany: effectiveness and safety of antiviral treatment in a real-world setting.
United European Gastroenterol J
; 6(2): 213-224, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29511551
5.
Effects of Smoking on Pegylated Interferon alpha 2a and First Generation Protease Inhibitor-based Antiviral Therapy in Naïve Patients Infected with Hepatitis C Virus Genotype 1.
J Gastrointestin Liver Dis
; 25(1): 15-24, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27014750
6.
Outcomes and Costs of Treating Hepatitis C Patients in the Era of First Generation Protease Inhibitors - Results from the PAN Study.
PLoS One
; 11(7): e0159976, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27467772
7.
Benefit of Treatment Individualization in Patients with Chronic Hepatitis C Receiving Peginterferon Alfa-2a and Ribavirin in a Large Noninterventional Cohort Study.
PLoS One
; 10(7): e0134839, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26230998
8.
Age-related differences in response to peginterferon alfa-2a/ribavirin in patients with chronic hepatitis C infection.
World J Gastroenterol
; 20(31): 10984-93, 2014 Aug 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-25152602
Resultados
1 -
8
de 8
1
Próxima >
>>